Re­call re­port: Acel­la pulls thy­roid tablets af­ter a raft of side ef­fect re­ports; mis­la­bel­ing caus­es Pfiz­er's Hos­pi­ra to yank 2 lots of anes­thet­ics

Acel­la Phar­ma­ceu­ti­cals has pulled its NP Thy­roid tablets off US shelves af­ter rou­tine test­ing found dif­fer­ent ver­sions of the drug not hit­ting po­ten­cy marks. In this case, that screw-up had an im­me­di­ate ef­fect on pa­tients with 43 re­ports of se­ri­ous side ef­fects, the FDA said.

The 38 re­called lots con­tained less than 90% of their la­beled amount of lio­thy­ro­nine and levothy­rox­ine, the FDA said. Of those lots, 35 of them were 100-count bot­tles of ei­ther 15mg, 120mg, 30mg, 60mg or 90 mg tablets. An­oth­er three were sev­en-count bot­tles of 15mg, 30mg and 120mg tablets.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER